Ocular Oncology

Top Story

Bevacizumab increases visual acuity in ocular melanoma patients treated with plaque radiotherapy

Bevacizumab increases visual acuity in ocular melanoma patients treated with plaque radiotherapy
March 13, 2020
In the JournalsPerspective

Iodine-125 brachytherapy treatment poses glaucoma risk

February 3, 2020
Patients treated with iodine-125 brachytherapy for uveal melanoma could have a substantial risk for developing open-angle or neovascular glaucoma. Of 374 eyes treated…
Point/Counter

What is your treatment process when a lifesaving therapy results in worsening ocular symptoms?

Ocular Surgery News U.S. Edition, January 25, 2020
As a retina specialist, my busy private practice sees a wide spectrum of the patient population. We have a significant number of patients on therapies for systemic…
Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be difficult to balance…
More Headlines »
Clinical Science

Ophthalmology Consultation to Detect Endogenous Endophthalmitis: Clinical Characteristics in Consulted Versus Diagnosed Cases Among At-Risk Inpatients

Ophthalmic Surgery, Lasers and Imaging Retina, March 2020, Volume 51 Issue 3
Predisposing factors for ophthalmology consultations and endogenous endophthalmitis were compared among inpatients with…
More »
Video

Uveal melanoma treatment improving but metastasis persists

September 30, 2016
More »